Tetrandrine triggers an alternative autophagy in DU145 cells

Wei Qiu1, Ai-Li Zhang2, Ye Tian1

  • 1Department of Urology, Beijing Friendship Hospital, Capital Medical University, Xicheng, Beijing 100050, P.R. China.

Oncology Letters
|May 23, 2017
PubMed

Insights

Tetrandrine blocks lysosome function and induces cancer cell death. In prostate cancer DU145 cells, it triggers autophagy independently of LC3, enhancing cell death when combined with chloroquine.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • Tetrandrine (Tet) is a lysosomal inhibitor known to block autophagic flux and induce cancer cell death.
  • Previous studies identified DU145 prostate cancer cells as highly sensitive to Tet.
  • Understanding Tet's mechanism in sensitive cell lines is crucial for targeted cancer therapy.

Purpose of the Study:

  • To investigate the specific effects of Tetrandrine on autophagy in DU145 prostate cancer cells.
  • To elucidate the mechanism of Tet-induced cell death in this specific cancer cell line.
  • To explore the potential of combining Tet with other agents to enhance therapeutic efficacy.

Main Methods:

  • Treatment of DU145 cells with Tetrandrine.
  • Analysis of lysosomal acidity and autophagic flux.
  • Assessment of microtubule-associated protein 1 light chain 3 (LC3) conversion.
  • Transmission electron microscopy to observe autophagosome accumulation.
  • Combination treatment with chloroquine to evaluate synergistic effects on cell death.

Main Results:

  • Tetrandrine neutralized lysosomal acidity and blocked autophagic flux in DU145 cells, similar to other cancer cell lines.
  • Contrary to expectations, Tetrandrine did not induce LC3 conversion in DU145 cells.
  • Transmission electron microscopy revealed an accumulation of autophagosomes, indicating LC3-independent autophagy.
  • Co-administration of chloroquine potentiated Tetrandrine-induced cancer cell death.

Conclusions:

  • Tetrandrine induces an LC3-independent autophagic response in DU145 prostate cancer cells.
  • Lysosomal inhibition by Tetrandrine enhances cancer cell death, particularly when combined with agents that further disrupt lysosomal function.
  • Monitoring autophagy in tumors may aid in selecting appropriate lysosomal inhibitors for prostate cancer chemotherapy.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K